Bacterin International announces third national GPO contract with Novation

Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces its third national GPO contract, a three-year agreement with Novation, a leading health care supply chain expert and contracting company.  The agreement provides Bacterin's full biologic portfolio, including OsteoSponge®, OsteoSelect® DBM Putty, OsteoWrap®, OsteoLock®, BacFast®, hMatrix®, Sports Medicine Allografts, and traditional allografts to the nationwide network of hospitals and medical practices served by Novation. The group purchasing agreement became effective, after performing months of research and evaluation of the Bacterin product lines.

"We are pleased to partner with Novation, an organization which has developed an industry-wide reputation for innovative, technology-driven, results-oriented approaches to improving supply chain performance," said Guy Cook, Chairman and CEO of Bacterin International. "The inclusion of our products in Novation's network is a significant opportunity to create exposure and access for physicians to our broad portfolio of biologics. Our sales reps are excited to begin calling on their facilities."